Quantitative magnetic resonance spectroscopic imaging in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy
暂无分享,去创建一个
G. Barker | D. Ståhl | D. Lythgoe | C. Blain | P. Leigh | C. Guevara
[1] G K Wenning,et al. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[2] H. Möller,et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. , 1995, Magnetic resonance in medicine.
[3] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[4] D. Brooks,et al. A Proton Magnetic Resonance Spectroscopy Study of the Striatum and Cerebral Cortex in Parkinson's Disease , 1999, Metabolic Brain Disease.
[5] T. Mareci,et al. Selective fourier transform localization , 1987, Magnetic resonance in medicine.
[6] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[7] C. Clarke,et al. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy , 2000, European journal of neurology.
[8] G J Barker,et al. Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.
[9] H. Bruhn,et al. Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.
[10] C. Clarke,et al. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes , 2001, European journal of neurology.
[11] M. Hallett,et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. , 1997, Brain : a journal of neurology.
[12] A. Horsman,et al. Unchanged basal ganglia N‐acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy , 1997, Movement disorders : official journal of the Movement Disorder Society.
[13] B D Ross,et al. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases , 1998, Neurology.
[14] M. T. Pellecchia,et al. Diffusion‐weighted imaging in multiple system atrophy: A comparison between clinical subtypes , 2009, Movement disorders : official journal of the Movement Disorder Society.
[15] N. Schuff,et al. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[16] David H. Miller,et al. Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome , 1997, Movement disorders : official journal of the Movement Disorder Society.
[17] Christian Kremser,et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.
[18] C Kremser,et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.
[19] Nick C. Fox,et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease , 2004, NeuroImage.
[20] I. McKeith,et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.
[21] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[22] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[23] M. Weiner,et al. Proton MR spectroscopic imaging of the striatum in Parkinson's disease. , 1997, Magnetic resonance imaging.
[24] D. Dubowitz,et al. In vivo magnetic resonance spectroscopy of human fetal neural transplants , 1999, NMR in biomedicine.
[25] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.
[26] Andrew J Lees,et al. Diffusion‐weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple‐system atrophy from progressive supranuclear palsy , 2007, Movement disorders : official journal of the Movement Disorder Society.
[27] Tae-Suk Suh,et al. Metabolic Alterations in Parkinson's Disease after Thalamotomy, as Revealed by 1H MR Spectroscopy , 2002, Korean journal of radiology.
[28] Francesco Fera,et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. , 2006, Brain : a journal of neurology.
[29] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[30] K. Abe,et al. Proton magnetic resonance spectroscopy of patients with parkinsonism , 2000, Brain Research Bulletin.
[31] H. Möller,et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic parkinson's disease: a multicenter pilot study , 1995 .
[32] C. Büchel,et al. Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.
[33] M. Tosetti,et al. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients , 2001, Neurological Sciences.
[34] A. Simmons,et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study , 1997, Neurology.
[35] A. Lees,et al. Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.
[36] Michael Schocke,et al. Progression of brain atrophy in multiple system atrophy , 2007, Journal of Neurology.
[37] H. Watanabe,et al. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[38] D Matthaei,et al. 1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.
[39] S Mierisová,et al. MR spectroscopy quantitation: a review of frequency domain methods , 2001, NMR in biomedicine.
[40] C. Marsden,et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.
[41] P. Lamberti,et al. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes , 1999, The Italian Journal of Neurological Sciences.
[42] Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations. , 1996, Parkinsonism & related disorders.
[43] Jan Aasly,et al. Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients , 2002, Journal of magnetic resonance imaging : JMRI.
[44] A. Mackay,et al. Proton T1 relaxation times of cerebral metabolites differ within and between regions of normal human brain , 2003, NMR in biomedicine.